|

PCSK9 inhibitors and background lipid-modifying therapy Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • PCSK91
  • CT Angiography1
  • Cardiovascular Events1
  • Heart Disease1
  • Coronary Artery Disease1

Other1 trial

Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.